MedPath

Canthaxanthin Retinopathy: A Long-term Observation

Completed
Conditions
Canthaxanthin Retinopathy
Registration Number
NCT01128062
Lead Sponsor
University of Cologne
Brief Summary

Canthaxanthine is a naturally occurring carotenoid that has been a popular over-the-counter oral artificial tanning agent in Europe, Canada, and Australia since 1979. It is also used at low dosage as a food-colouring agent and as a therapeutic agent for photosensitivity disorders such as erythropoietic protoporphyria. Canthaxanthin retinopathy was first described in 1982 by Cortin et al. In Germany the office of the federal board of health refused the permit for oral tanning agents containing canthaxanthine in 1985. At that time the long-term course of the disease was not known. 25 years later the investigators did these long-term follow-up examinations.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • patients using oral tanning agents for at least 2 months.
  • patients of 18 years or older
Exclusion Criteria
  • none.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
all eye diseases2008 and 2009

All patients will have the follow-up examination 2008 or 2009. The examination included at most visual acuity (distant and near vision), Amsler test, examination of anterior segment, posterior segment, 10-2 and 30-2 visual field, electrooculography, electroretinography, multifocal electroretinography, fundus photography, fluorescein angiography, and an examination for autofluorescence.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Eye Hospital, University of Cologne

🇩🇪

Cologne, NRW, Germany

© Copyright 2025. All Rights Reserved by MedPath